Monte Rosa Therapeutics, Inc. (GLUE)
17.03
-0.82
(-4.59%)
USD |
NASDAQ |
Dec 09, 16:00
16.99
-0.04
(-0.23%)
After-Hours: 20:00
Monte Rosa Therapeutics Shareholders Equity (Quarterly): 245.84M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Novartis AG | 44.33B |
| AVITA Medical, Inc. | -6.666M |
| NanoVibronix, Inc. | 42.46M |
| Mirum Pharmaceuticals, Inc. | 292.05M |
| Day One Biopharmaceuticals, Inc. | 450.87M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 459.84M |
| Total Liabilities (Quarterly) | 214.00M |
| Debt to Equity Ratio | 0.1634 |
| Current Ratio | 6.540 |
| Net Debt Paydown Yield | 0.18% |